GLPBio

Metabolism

Research Areas

Products Related to Metabolism(3154)

  • GC79071 structure
    GC79071Apidaecin IA acetate
    Purity: >98.00%

    Apidaecin IA acetate is a basic peptide.

  • GC79073 structure
    GC79073HSF1-IN-2
    CAS: 304453-52-9
    Purity: >98.00%

    HSF1-IN-2 (Compound 0048) is a HSF1 inhibitor.

  • GC79074 structure
    GC79074HSP70/DnaK substrate peptide TFA
    Purity: >98.00%

    HSP70/DnaK substrate peptide TFA is a short peptide that the HSP70/DnaK molecular chaperone can bind and act on.

  • GC79077 structure
    GC79077DDO-6600
    CAS: 2640292-37-9
    Purity: >98.00%

    DDO-6600 is a covalent Hsp90 inhibitor.

  • GC79118 structure
    GC79118Hydrangeic acid
    CAS: 491-79-2
    Purity: >96.00%

    Hydrangeic acid is an orally effective stilbene-type glycolipid metabolism regulator that lowers blood glucose and lipids.

  • GC79119 structure
    GC79119PPARα agonist 6
    CAS: 959699-23-1
    Purity: >99.50%

    PPARα agonist 6 (Compound 15) is a PPARα agonist.

  • GC79120 structure
    GC79120EL244
    CAS: 3047548-70-6
    Purity: >99.50%

    EL244 is a dua Autotaxin ( ATX ) ( IC 50 = 50 nM) inhibitor and PPARγ ( IC 50 = 1.3 μM; K d = 1.3 μM) agonist.

  • GC79167 structure
    GC79167METTL1-WDR4-IN-1 TFA
    Purity: >99.50%

    METTL1-WDR4-IN-1 (Compound 1) TFA is a selective competitive inhibitor of the methyltransferase complex METTL1-WDR4 ( IC 50 =144 μM).

  • GC79168 structure
    GC79168EP102
    CAS: 3050818-07-7
    Purity: >98.00%

    EP102 is an orally active, selective inhibitor of the METTL3/METTL14 complex with an IC 50 of 2 nM.

  • GC79251 structure
    GC79251PBF-999
    CAS: 1620909-95-6
    Purity: >98.50%

    PBF-999 is a phosphodiesterase10A (PDE-10A) and adenosine A2A receptor (A2AR) dual antagonist.

  • GC79293 structure
    GC79293PIPE-791
    CAS: 2901868-37-7
    Purity: >98.00%

    PIPE-791 is an orally active, blood-brain barrier-permeable selective antagonist of LPAR1.

  • GC79301 structure
    GC79301GS-5759
    CAS: 1346653-91-5
    Purity: >99.00%

    GS-5759 is both a β₂-adrenergic receptor agonist and a PDE4 inhibitor.

  • GC79337 structure
    GC79337ZSTK3744
    Purity: >98.00%

    ZSTK3744 is an aryl hydrocarbon receptor ( AhR ) agonist.

  • GC79393 structure
    GC79393PY109
    CAS: 2378039-23-5
    Purity: >99.00%

    PY109 is an orally active and highly selective aryl hydrocarbon receptor ( AHR ) agonist.

  • GC79394 structure
    GC79394IL4RPep-1 acetate
    Purity: >98.50%

    IL4RPep-1 acetate is an interleukin-4 receptor ( IL-4R ) binding agent.

  • GC79395 structure
    GC79395NT-0527
    CAS: 2771019-10-2
    Purity: >99.50%

    NT-0527 is a selective, orally active, and brain-permeable NLRP3 inflammasome inhibitor.

  • GC79396 structure
    GC79396Anti-CD3 Antibody (UCHT-1)
    Purity: >97.00%

    Anti-CD3 Antibody (UCHT-1) is an antibody targeting CD3.

  • GC79451 structure
    GC79451JP-11646
    CAS: 1902983-63-4
    Purity: >98.50%

    JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 ( IC 50 = 0.5 nM).

  • GC79563 structure
    GC79563(rac)-BDM88951
    Purity: >98.50%

    (rac)-BDM88951 is the racemate of BDM88951.

  • GC79564 structure
    GC79564Corveldebart
    CAS: 3062245-47-7
    Purity: >99.50%

    Corveldebart is a monoclonal antibody of immunoglobulin G1-kappa that targets ANGPTL4.

  • GC79566 structure
    GC79566DHODH-IN-31
    Purity: >99.50%

    DHODH-IN-31 is a human dihydroorotate dehydrogenase ( DHODH ) inhibitor with an IC 50 of 0.59 μM.

  • GC79571 structure
    GC79571CAI0019
    CAS: 2446169-48-6
    Purity: >98.00%

    CAI0019 is an orally active α-carbonic anhydrase inhibitor based on the Acetazolamide framework.

  • GC79585 structure
    GC79585UBA6-IN-1
    CAS: 1557137-61-7
    Purity: >99.00%

    UBA6-IN-1 is a UBA6/UBE1L2 inhibitor ( IC 50 ≤50 nM) that acts by reducing the level of squalene epoxidase ( SQLE ).

  • GC79586 structure
    GC79586(±)Homoeriodictyol
    CAS: 69097-98-9
    Purity: >98.00%

    (±) Homoeriodictyol is a Aromatase/CYP19 inhibitor that can be used in breast cancer research [1] .